Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Why Bausch Health Is Down More Than 24% Today
01:06pm, Tuesday, 10'th May 2022
The company shocked investors with its loss, although today may also be a major capitulation for the stock.
Bausch (BHC) Q1 Earnings and Revenues Miss, Stock Down
12:48pm, Tuesday, 10'th May 2022
Bausch (BHC) misses on earnings and sales in the first quarter due to incremental macro pressures and a challenging supply chain environment.
Bausch Health's Q1 Sales, Profits Fall On Supply Chain Challenges, Cuts FY22 Outlook
12:25pm, Tuesday, 10'th May 2022
Bausch Health Companies Inc (NYSE: BHC) has reported Q1 revenues of $1.92 billion, down 5% Y/Y. Excluding the unfavorable impact of foreign exchange of $41 million and divestitures & discontinuation
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO
11:06am, Tuesday, 10'th May 2022
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022. The post Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO appea
Bausch Health Companies Inc. (BHC) CEO Joe Papa on Q1 2022 Results - Earnings Call Transcript
09:56am, Tuesday, 10'th May 2022
Bausch Health Companies Inc. (NYSE:BHC ) Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Joe Papa - Chairman and Chief Executive Officer Thomas Appio - Chief Executive Of
Bausch Health's stock falls 32% on revenue and earnings miss in Q1
08:13am, Tuesday, 10'th May 2022
Shares of Bausch Health Cos. Inc. BHC, -19.58% tumbled 32.0% in premarket trading on Tuesday after the company missed revenue and earnings expectations for the first quarter.
RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow
07:32pm, Monday, 09'th May 2022 Benzinga
RBC Capital Markets expects Bausch Health Companies Inc (NYSE: BHC) Q1 FY22 revenue of $2.02 billion (previous $2.04 billion; consensus $2.05 billion) and adjusted EBITDA of $799 million (previous
RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow
03:42pm, Monday, 09'th May 2022
RBC Capital Markets expects Bausch Health Companies Inc (NYSE: BHC) Q1 FY22 revenue of $2.02 billion (previous $2.04 billion; consensus $2.05 billion) and adjusted EBITDA of $799 million (previous
Drug/Biotech Stocks' Q1 Earnings on May 10: EXEL, BHC & More
03:37pm, Monday, 09'th May 2022 Zacks Investment Research
Let's look at the five biotech/drug companies that are slated to release quarterly results on May 10.
Drug/Biotech Stocks' Q1 Earnings on May 10: EXEL, BHC & More
12:47pm, Monday, 09'th May 2022
Let's look at the five biotech/drug companies that are slated to release quarterly results on May 10.
BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today
02:11pm, Friday, 06'th May 2022
Here's what investors in Bausch + Lomb may want to know about the highly anticipated BLCO stock IPO, which took place today. The post BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today app
Bausch + Lomb valued at $6.5 billion after stock ticks up in NYSE debut
01:34pm, Friday, 06'th May 2022
(Reuters) -Bausch + Lomb was valued at $6.48 billion in its U.S. market debut on Friday as the eye-care company's shares opened nearly 3% above an offer price that was well below the targeted range.
Bausch + Lomb IPO prices below range after carnage in stock market
10:38am, Friday, 06'th May 2022 MarketWatch
The U.S. initial public offering market has been 'brutal' amid rising interest rates that have hit growth stocks especially hard.
Bausch + Lomb prices IPO at $18 a share, below expectations
12:10am, Friday, 06'th May 2022
Bausch + Lomb Corp. priced its IPO at $18 a share Thursday, falling short of expectations as it became the first big company in months to try going public into a turbulent stock market.
Bausch + Lomb prices IPO at $18 a share, below expectations
11:31pm, Thursday, 05'th May 2022 MarketWatch
Bausch Health Cos., the parent company, raised $630 million in the offering. It had been aiming to raise as much as $840 million and sell the stock at $21 to $24 a share, according to a regulatory fi
